They may have some questions for you
As of May 2026, BPC-157 remains on the FDAs Category 2 restricted list, pending advisory-committee review
Eighth, it activates the Wnt/-Catenin signaling pathway, one of the master regulators of hair follicle development and cycling
Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor
Our top picks from Timeline and Codeage fall into this category, but our pick from Perpetua.Life manages to maintain quality and safety for under $60 per bottle (or under $50 with a subscription)
Katelyn Jetelina, MPH PhDan epidemiologist, wife, and mom of two little girls